You ran Phase 1. The wall is being rebuilt. BPC-157 is on board, the diet is clean, the injection sites are rotating. And the bloat is still there at Week 3. The stool is still erratic. Sleep is light. The protocol looks correct on paper and the gut is not responding. This is the chapter where most self-experimenters quit, and it is almost always the same failure mode: the nervous system is still in sympathetic lock, and a sympathetic-locked gut cannot heal regardless of what compound you put into it.
The practitioner corpus is unambiguous on this. Under chronic sympathetic dominance, digestion shuts off. Stomach acid production tanks. Intestinal motility becomes erratic at best. Systemic inflammation rises. And the same corticotropin-releasing factors (CRFs) that coordinate the stress response have potent direct effects on the gut — they increase intestinal permeability and contribute to what's called visceral hypersensitivity. You are giving BPC-157 the job of sealing a wall that cortisol is actively pulling apart from the basement membrane up. This phase exists to break that loop.
What's actually happening
Three structures matter here, and they are wired together.
The vagus nerve runs the show downstream of the stomach. It controls peristalsis — the wave that moves stool through the GI tract. It controls the ileocecal valve, the gate between small intestine and colon that prevents colonic flora from refluxing upward. And it drives the migrating motor complex (MMC) — the cleaning wave that sweeps residual food and bacterial load out of the small bowel between meals. When vagal tone is low, the MMC stops firing, the ileocecal valve gets sloppy, and you grow bacterial overgrowth in a compartment that was supposed to stay relatively sterile. The corpus is explicit on this: gastro-motility is linked to the MMC, the MMC is triggered by signals from the vagus nerve, and the valve function is vagally mediated. SIBO and the bloat pattern that comes with it is a downstream symptom of a vagal tone problem in most of these cases — not a primary microbial event.
Cortisol degrades the wall faster than BPC-157 can rebuild it. Chronic HPA-axis activation thins the gut mucosa and lowers secretory IgA — the antibody layer that sits on top of the mucus and shapes which microbes get to colonize. Low sIgA means you lose the immunological gate above the epithelial gate. CRH released from the hypothalamus also acts peripherally on mast cells in the gut wall, driving tight-junction loosening directly. This is the cortisol-permeability axis the corpus repeatedly returns to, and it is the reason a "perfect" Phase 1 stack stalls in someone whose sleep is short, whose mornings start in fight-or-flight, and whose evenings end in screen-blue cortisol spikes.
The HPA-gut loop is bidirectional. The enteric nervous system feeds back to the brain through that same vagus nerve. Gut inflammation, dysbiosis, and barrier disruption are themselves anxiogenic inputs — they tell the brain something is wrong, the brain raises CRH, CRH raises cortisol, cortisol lowers sIgA and loosens junctions, and the loop tightens. You have to break it from both ends in the same phase or you will keep running in circles.
The Phase 2-A supporting stack
This stack runs concurrently with the gut-wall stack (BPC-157 / KPV / glutamine carry forward from Phase 1). It does not replace it. It addresses the upstream nervous-system driver so the wall stack can actually do its job.
| Compound | Dose | Route | Frequency | Evidence Tier | Notes |
|---|---|---|---|---|---|
| Selank | 200–400 mcg | Intranasal | 2–3x/day | 🟢 Expert | Anxiolytic without sedation, cognitive impairment, or addiction potential. Modulates BDNF and reduces HPA tone via melanocortin-adjacent pathways. Use as the daytime nervous-system reset. |
| Selank (alt schedule) | 200–400 mcg | Intranasal | 1–2x/day | 🟢 Expert | 30 days on / 10 days off cycle when running long. Same per-dose range, lower daily frequency. |
| Semax | 200–600 mcg | Intranasal | 1–2x/day | 🟢 Expert | Pair with Selank when there is cognitive blunting alongside the anxiety pattern. 30 days on / 10 days off. Morning dosing — not before sleep. |
| DSIP | [practitioner corpus thin on dose specifics for the gut-repair context — track and report] | Subcutaneous | Pre-sleep | 🟣 Experimental | Sleep architecture support when sleep latency or fragmentation is the limiting factor. Optional add-on. |
The Selank piece is the load-bearing one. The corpus describes it as anxiolytic without the sedation, cognitive impairment, or addiction profile of benzodiazepines — which matters because the sympathetic-lock pattern in the gut-repair audience is usually chronic and the "fix" cannot itself become the next dependency. Selank pulls daytime CRH tone down, which is what you actually need to give the gut wall a window to seal.
The non-compound layer (do this or the stack underperforms)
These are not negotiable inside this phase. They are the substrate-cited circadian and digestive supports that determine whether the peptide stack lands.
- 8–12 hour feeding window, anchored to daylight. Stop eating at least 3 hours before bed. The corpus is consistent that eating against circadian rhythm — late meals, midnight snacks — keeps the gut in digestion mode when it should be in MMC-sweep mode. The MMC fires in fasted states. Constant snacking shuts it off.
- Morning sunlight in the first 30 minutes after waking. This is the SCN reset that anchors the cortisol awakening response to the front of the day instead of the middle of the night.
- Digestive support at meals during Phase 2. Stomach acid production is suppressed under chronic sympathetic load. Bitters, betaine HCl with pepsin (if no ulcer history), or ox bile for fat digestion bridge the gap until vagal tone restores endogenous secretion. The corpus repeatedly cites this as a precondition for downstream healing.
- A daily vagal stimulation practice. Cold-water face immersion, slow nasal breathing at 5.5 breaths/min, or humming/gargling for 2–3 minutes morning and evening. Cheap, free, mechanism-grounded — these drive parasympathetic activation through the vagus afferents and they stack additively with Selank.
What you should feel
- Week 1: Selank takes the edge off within 20–40 minutes of the first intranasal dose. The reset is noticeable, not dramatic. Sleep latency often shortens by Day 3–5.
- Week 2: Morning bloat begins to soften. Bowel movements consolidate. The ileocecal "click" some people get on the right lower quadrant either resolves or becomes far less reactive to meals.
- Week 3: Cognitive bandwidth comes back. The corpus describes this as the point where users notice they are responding to stressors instead of reacting. This is the marker that vagal tone is rebuilding and CRH baseline is dropping.
- Week 4: Sleep stages deepen. GH pulse during slow-wave sleep — which is itself a gut-repair signal — recovers. This is what the corpus means when it calls sleep the repair window.
What's NOT happening yet
- Selank is not sedation. If it is making you sleepy, the dose is wrong or the timing is wrong. It is daytime calm, not nighttime knockout. DSIP is the sleep layer; Selank is not.
- Vagal tone does not rebuild in a week. The MMC re-establishment is a 3–6 week process under best conditions. Expecting the bloat to be gone by Day 7 will get you to abandon the stack before it works.
- This phase does not replace the wall stack. BPC-157 / KPV / glutamine continue. You are adding the supporting axis, not swapping it in.
- Cortisol-lowering compounds are not in this phase. No adaptogen mega-stacks, no phosphatidylserine megadoses, no aggressive ashwagandha protocols layered on top. The corpus is clear that crashing cortisol pharmacologically while the upstream driver is unaddressed produces a different problem. Selank works upstream of cortisol, on the CRH side. That is the correct lever.
- SSRIs and Selank/Semax stacks need care. The corpus flags serotonergic interaction concerns with methylene blue in particular; for Selank and Semax specifically, the mechanism is melanocortin-adjacent and BDNF-mediated rather than direct monoaminergic, but if you are on an SSRI/SNRI/MAOI, this is not the phase to be casual about adding nasal peptides without a baseline.
The corpus is consistent: rebuild the wall, silence the fire, then bring the nervous system out of sympathetic lock so the wall stack can land — and run the circadian layer like it's the protocol itself, because for this phase, it is.